Lymphknotenmetastasen bei Plattenepithelfrühkarzinomen des Ösophagus

Lymph node metastasis in superficial squamous carcinoma of the esophagus

Der Pathologe volume 34, pages148–154(2013)Cite this article

Zusammenfassung

Die Definition der Plattenepithelfrühkarzinome des Ösophagus hat sich im Laufe der Zeit geändert. Seit 2007 wird das Frühkarzinom als intramukosales Karzinom mit oder ohne Metastasen definiert. In der Subklassifikation der Invasionstiefe weisen mukosale m1- und m2-Plattenepithelkarzinome praktisch keine Metastasen auf und gelten als endoskopisch heilbar. Dagegen bilden 10% der m3-Karzinome und etwa 20% der sm1-Plattenepithelkarzinome Lymphknotenmetastasen aus. In der vorliegenden Arbeit wird die Beziehung zwischen verschiedenen histopathologischen Befunden bei m3- und sm1-Plattenepithelkarzinomen und dem Auftreten von Lymphknotenmetastasen bewertet. Nach der Paris-Klassifikation und der Größe werden endoskopisch folgende Typen unterschieden: 0-I- und 0-III-Typen sowie große Tumoren über 50 mm Größe. Tumoren mit Gefäßeinbrüchen weisen ebenfalls eine höhere Inzidenz von Lymphknotenmetastasen auf. Wichtig für Pathologen ist, dass von klinischer Seite in der Magen-Darm-Pathologie erwartet wird, dass histologisch nicht nur eine Malignitätsbewertung durchgeführt, sondern auch im Detail auf Risikofaktoren für Lymphknotenmetastasen eingegangen wird.

Abstract

The definition of early carcinoma of the esophagus has changed with time on the basis of new data. As from 2007 an early carcinoma is defined as an intramucosal carcinoma with or without metastasis. In the subclassification based on invasion depth, m1 and m2 squamous cell carcinomas have no metastasis and are considered curable by endoscopic resection alone, whereas less than 10% of m3 carcinomas and some 20% of sm1 squamous cell carcinomas have lymph node metastasis. In this article the relationship between various histopathological findings and the incidence of lymph node metastasis is reviewed. The m3 and sm1 superficial squamous cell carcinomas showing 0-I and 0-III types, large tumors over 50 mm in size or those showing vessel permeation have higher incidences of lymph node metastasis. In the field of gastrointestinal surgical pathology pathologists are now expected to not only diagnose the presence or absence of malignancy but also to investigate in detail many of the histological factors related to the prevalence of lymph node metastasis.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

US$ 39.95

Tax calculation will be finalised during checkout.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. 1.

    Endo M, Takeshita K, Kawano T et al (1998) Indication: endoscopic treatment for early carcinoma of the esophagus. In: Okubo A, Kimura K, Imawari M, Nakamura T (Hrsg) Shokaki-Shinryo practice. Bunkodo, Tokyo, S 139–142

  2. 2.

    Fujita M, Satoh T, Hosokawa M et al (2006) Lymph node metastasis in surgical specimens of m3 and sm esophageal carcinoma from a pathological viewpoint. I to cho (Stomach and Intestine) 41:1407–1415

    Google Scholar 

  3. 3.

    Japanese Society for Esophageal Diseases (1969) Guidelines for clinical and pathologic studies on carcinoma of the esophagus. Kanehara Co. Ltd., Tokyo

  4. 4.

    Juan R (2011) In situ and superficial squamous cell carcinoma and related lesions. Rosai and Ackerman’s surgical pathology, 10. Aufl. Elsevier, Edinburgh, S 595–596

  5. 5.

    Makuuchi H (2003) EMR against m3 sm1 carcinomas of the esophagus. Rinsho-Shokakinaika (Clin Gastroenterol) 18:1487–1492

  6. 6.

    Makuuchi H, Shimada H, Chino O et al (1997) Survival of patients with superficial squamous cell carcinoma of the esophagus treated by esophagectomy. Rinsho-Shokakinaika (Clin Gastroenterol) 12:1749–1756

    Google Scholar 

  7. 7.

    Makuuchi H, Shimada H, Chino O et al (2002) Long term prognosis of m3, sm1 cancer of the esophagus – comparison between EMR and radical surgery cases. I to cho (Stomach and Intestine) 37:53–63

    Google Scholar 

  8. 8.

    Makuuchi H, Shimada H, Chino O et al (2009) Indications for endoscopic resection for esophageal squamous cell carcinoma. I to cho (Stomach and Intestine) 44:311–324

    Google Scholar 

  9. 9.

    Nakayama K, Hanyu F, Iwatsuka M (1966) A case of early esophageal carcinoma. Geka Shinryou (Surgical Treatment) 8:1224–1226

    Google Scholar 

  10. 10.

    Nemoto T, Ito T, Horiguchi S et al (2006) Lymph node metastasis of m3 and sm esophageal squamous cell carcinoma – analysis of 95 surgically resected cases. I to cho (Stomach and Intestine) 41:1416–1427

    Google Scholar 

  11. 11.

    Oyama T, Miyata Y, Shimatani S et al (2002) Lymph node metastasis of m3 and sm1 esophageal cancer. I to cho (Stomach and Intestine) 37:71–74

    Google Scholar 

  12. 12.

    Siewert JR (2004) Current status of esophageal cancer – West versus East: the European point of view. Esophagus 1:147–159

    Article  Google Scholar 

  13. 13.

    Takubo K, Arai T, Sawabe M et al (2002) Superficial carcinoma of the esophagus in Japan: curable lesion. In: Imamura M (Hrsg) Superficial esophageal neoplasms: pathology, diagnosis and therapy. Springer, Tokyo, S 21–27

  14. 14.

    Takubo K (2007) Histological growth pattern. Pathology of the esophagus, 2. Aufl. Springer, Tokyo, S 166

  15. 15.

    The Japan Esophageal Society (2012) Comprehensive registry of esophageal cancer in Japan in the website of the Japan Esophageal Society. http://esophagus.jp/. Zugegriffen: 18. Juni 2012

  16. 16.

    The Japan Esophageal Society (2008) Guidelines for clinical and pathologic studies on carcinoma of the esophagus, 10. Aufl. Kanehara Co. Ltd, Tokyo

  17. 17.

    The Japan Esophageal Society (2012) The esophageal cancer treatment guideline, 3. Aufl. Kanehara Co. Ltd, Tokyo

  18. 18.

    Yamagata S, Ishikawa M, Oshiba S (1966) A case of early esophageal carcinoma diagnosed by cytology. I to cho (Stomach and Intestine) 1:259–266

    Google Scholar 

  19. 19.

    Yoshida M, Ishiguro S, Koike M (2000) Report on the study committee of EMR. Japan Esophageal Society, Chiba-city

Download references

Interessenkonflikt

Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.

Author information

Affiliations

  1. Research Team for Geriatric Pathology, Tokyo Metropolitan Institute of Gerontology, and Department of Pathology, Tokyo Metropolitan Geriatric Medical Center, Sakae-cho 35–2, Itabashi-ku, 173–0015, Tokyo, Japan

    Dr. K. Takubo, J. Aida & T. Arai

  2. Department of Surgery, Tokai University Hachioji Hospital, 192–0032, Hachioji City, Japan

    H. Makuuchi

  3. Department of Gastroenterology, Saitama Cancer Center, 362–0806, Ina-machi, Saitama-ken, Japan

    M. Arima

  4. Institut für Pathologie, Klinikum Bayreuth, Bayreuth, Deutschland

    M. Vieth

Authors
  1. Dr. K. Takubo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Makuuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Arima
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Aida
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Arai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Vieth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dr. K. Takubo.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Takubo, K., Makuuchi, H., Arima, M. et al. Lymphknotenmetastasen bei Plattenepithelfrühkarzinomen des Ösophagus. Pathologe 34, 148–154 (2013). https://doi.org/10.1007/s00292-012-1730-5

Download citation

Schlüsselwörter

  • Frühkarzinom
  • Oberflächliche Karzinome
  • Ösophaguskarzinom
  • Plattenepithelkarzinom
  • Lymphknotenmetastasen

Keywords

  • Early esophageal carcinoma
  • Superficial carcinoma
  • Esophageal carcinoma
  • Squamous cell carcinoma
  • Lymph node metastasis